Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS

CliniSenz(TM) - A Cost-effective Biosensor for Automatic Continuous Blood Glucose Monitoring

Objective

We are a Swedish medical devices manufacture, Senzime AB, who have been driven by the need to take advantage of an existing core technology to embark on a new strategy to grow based on our vision of becoming the leading provider of analyte evaluation systems, with a turnover of €30.5m by 2020.

To realise this vison we will add a new product line to our portfolio by exploiting an existing biosensor technology that we have developed, as well as the experience and contacts gained on a parallel project, which is currently yielding high growth. We have identified within our target market the need of health care providers to be able to track blood glucose levels continuously which is not currently being met in a cost effective and practical way by existing products.

To overcome these deficiencies we have developed the CliniSenzTM system with innovative features and functionality which in turn creates performance advantages of being more sensitive, specific and continuous. These performance advantages, in turn generate real commercial customer benefits, such as reduced mortality rates, faster recovery rates and the freeing up of healthcare professionals. Since 2004 Senzime has been working to develop prototypes and has conducted clinical trials which has allowed us to have achieved TRL 6. We now seek to create a feasibility report and detailed business/investment plan which will enable us to secure funding to reach TRL 8 and launch the product. This new product will be key to realising our growth strategy relating to achieving growth in sales. Based on projected demand from ICUs across the UK and US, we have forecasted sales worth €30.5 million to us by 2020.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

You need to log in or register to use this function

Programme(s)

Multi-annual funding programmes that define the EU’s priorities for research and innovation.

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

SME-1 - SME instrument phase 1

See all projects funded under this funding scheme

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

(opens in new window) H2020-SMEInst-2014-2015

See all projects funded under this call

Coordinator

SENZIME AB
Net EU contribution

Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.

€ 50 000,00
Address
VALLVAGEN 4A
756 51 UPPSALA
Sweden

See on map

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Region
Östra Sverige Östra Mellansverige Uppsala län
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

€ 71 429,00
My booklet 0 0